Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

KTRA | Kintara Therapeutics Inc

Index- P/E- EPS (ttm)-9.41 Insider Own4.50% Shs Outstand1.69M Perf Week-6.90%
Market Cap6.80M Forward P/E- EPS next Y-0.61 Insider Trans0.00% Shs Float1.66M Perf Month-10.93%
Income-15.02M PEG- EPS next Q-0.58 Inst Own2.67% Short Float / Ratio0.58% / 0.43 Perf Quarter-24.95%
Sales0.00M P/S- EPS this Y88.78% Inst Trans- Short Interest0.01M Perf Half Y8.31%
Book/sh-5.86 P/B- EPS next Y40.87% ROA-147.03% Target Price14.00 Perf Year-19.30%
Cash/sh0.88 P/C4.45 EPS next 5Y- ROE-233.90% 52W Range2.70 - 15.50 Perf YTD-43.25%
Dividend- P/FCF- EPS past 5Y49.09% ROI-2054.58% 52W High-74.77% Beta0.99
Dividend %- Quick Ratio1.06 Sales past 5Y0.00% Gross Margin- 52W Low44.81% ATR0.38
Employees17 Current Ratio1.06 Sales Q/Q- Oper. Margin0.00% RSI (14)45.17 Volatility9.47% 9.74%
OptionableNo Debt/Eq0.00 EPS Q/Q52.55% Profit Margin- Rel Volume0.60 Prev Close3.87
ShortableYes LT Debt/Eq0.00 EarningsSep 18 AMC Payout- Avg Volume22.19K Price3.91
Recom2.00 SMA20-5.66% SMA50-4.31% SMA200-13.74% Volume13,268 Change1.03%
Oct-02-23 08:00AM
Sep-25-23 07:30AM
Sep-21-23 09:35AM
Sep-18-23 04:25PM
Sep-05-23 08:00AM
05:00PM Loading…
Aug-17-23 05:00PM
Aug-09-23 08:16AM
Aug-08-23 07:00AM
Jul-19-23 08:00AM
Jun-30-23 11:07AM
Jun-28-23 04:15PM
Jun-16-23 08:00AM
May-19-23 08:30AM
May-11-23 08:15AM
May-09-23 07:15AM
08:30AM Loading…
May-08-23 08:30AM
May-01-23 08:30AM
Apr-14-23 12:00PM
Mar-15-23 08:00AM
Mar-10-23 08:30AM
Feb-14-23 05:00PM
Jan-30-23 08:00AM
Jan-09-23 08:30AM
Dec-15-22 08:00AM
Dec-02-22 09:47AM
Dec-01-22 08:00AM
Nov-30-22 08:00AM
Nov-28-22 08:00AM
Nov-18-22 08:00AM
Nov-11-22 08:00AM
05:20PM Loading…
Nov-09-22 05:20PM
Oct-19-22 08:15AM
Sep-27-22 08:15AM
Sep-08-22 07:00AM
Aug-09-22 09:00AM
Aug-03-22 08:30AM
Jun-21-22 08:00AM
Jun-15-22 09:00AM
Jun-10-22 09:00AM
Jun-03-22 09:00AM
May-27-22 09:30AM
May-17-22 07:00AM
May-13-22 08:00AM
Apr-27-22 09:00AM
Apr-26-22 07:30AM
Apr-14-22 04:05PM
Apr-12-22 11:47AM
Apr-11-22 02:30PM
Mar-22-22 08:00AM
Mar-15-22 07:00AM
Feb-14-22 06:10AM
Feb-11-22 08:15AM
Feb-04-22 07:00AM
Feb-03-22 07:00AM
Jan-25-22 07:45AM
Jan-12-22 08:00AM
Jan-05-22 08:00AM
Dec-07-21 08:00AM
Nov-30-21 08:00AM
Nov-18-21 08:00AM
Nov-17-21 04:42AM
Nov-15-21 08:15AM
Nov-11-21 08:30AM
Nov-09-21 08:00AM
Nov-03-21 11:13AM
Oct-14-21 05:00AM
Oct-11-21 08:00AM
Sep-29-21 08:00AM
Sep-28-21 01:33PM
Sep-27-21 05:04AM
Sep-24-21 08:00AM
Sep-22-21 12:30PM
Aug-17-21 08:00AM
Aug-12-21 08:00AM
Aug-06-21 10:20AM
Aug-04-21 08:00AM
Jul-09-21 06:29AM
Jul-07-21 12:56PM
Jul-01-21 01:36PM
Jun-13-21 10:20PM
Jun-07-21 08:00AM
Jun-03-21 08:00AM
Jun-02-21 08:00AM
May-26-21 12:25PM
May-14-21 08:00AM
May-11-21 07:00AM
May-05-21 08:00AM
May-04-21 08:00AM
Apr-12-21 08:00AM
Apr-05-21 10:51AM
Mar-17-21 08:00AM
Mar-10-21 08:00AM
Mar-03-21 08:00AM
Mar-02-21 08:00AM
Mar-01-21 05:36AM
Feb-17-21 08:00AM
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.